Welcome to the Columbia University Medical Center's Office of Government & Community Affairs (GCA) web site. Government & Community Affairs represents the interests of Columbia University Medical Center before the federal, state, and city governments. This office also develops and implements programs with the communities surrounding Columbia University Medical Center and serves as the primary liaison between the Medical Center and the external community.
GCA coordinates information on services and programs available at the Medical Center campus. The office responds to and engages community stakeholders, local residents and community based providers as they seek to learn more about the various medical center programs, services, events and activities. We work with various elected officials, medical associations and other organizations to advocate and educate policy makers on areas ofinterest of our faculty and staff.
If you have any need or desire to work with elected officials or community based organizations, I strongly encourage you to contact us to see if we may be of assistance.
Ross A. Frommer
Vice President and Associate Dean
Dr. Wendy Chung Participates in Capitol Briefing on Precision Medicine
On Monday, April 20th, the Healthcare Leadership Council (HLC) hosted a briefing highlighting the ongoing strides in making precision medicine a reality in everyday healthcare. After brief remarks by HLC President Ms. Mary R. Grealy and Dr. Marc Grodman, CEO of Bio-Reference Laboratories, Inc. and a member of the HLC, an expert panel that included Dr. Robert Daber, Bio-Reference Laboratories; Dr. Richard Weinshilboum, Mayo Clinic; and Dr. Wendy Chung, Columbia University/New York-Presbyterian discussed the latest advances in precision medicine and what it could mean for scientists, policy makers, and most importantly, patients.
Dr. Daber discussed the number of unique mutations seen in analysis, which has led to an explosion of therapies guided by molecular targets. He noted that clinical trials have been transformed by molecular testing and are now widely based on molecular profiles. Dr. Weinshilboum talked about the need for a robust infrastructure to translate genomic science from promise to practice. He emphasized the importance of collaborating and sharing data, stating that one organization alone cannot succeed in integrating genome based knowledge into personalized care.
Dr. Chung brought it all home by providing examples of how early genetic testing has allowed for immediate diagnosis and treatment, an improvement upon the costly trial and error approach. She acknowledged that the cost of sequencing still needs to be reduced and that access to testing is not universal, but consistent and robust funding of the National Institutes of Health NIH is crucial to making that happen.
For more information, the briefing materials provided by the presenters are available here.
“Watch as Dr. Richard Mayeux, Chairman of Neurology at Columbia University Medical Center, discuss Alzheimer’s Disease research”
Virtual Tour of the Washington Heights & Inwood communities:
MCNF Annual Appeal To donate click on the pledge card, print and mail completed form to:
Office of Government & Community Affairs
51 Audubon Avenue8th Floor, Suite 800New York, N.Y. 10032
Research Means Hope
Support Funding for the National
Institutes of Health